Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open‐label study

• Zhichao Wang,
• Xin Zhang,
• Chunyan Li,
• Yangbo Liu,
• Xiaoyun Ge,
• Jiajia Zhao,
• Xiaojun Yuan,
• Qingfeng Li

Affiliations

Zhichao Wang

Shanghai Ninth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai China

Xin Zhang

Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai China

Chunyan Li

AstraZeneca Global R&D (China) Co. Ltd. Shanghai China

Yangbo Liu

AstraZeneca Global R&D (China) Co. Ltd. Shanghai China

Xiaoyun Ge

AstraZeneca Global R&D (China) Co. Ltd. Shanghai China

Jiajia Zhao

AstraZeneca Global R&D (China) Co. Ltd. Shanghai China

Xiaojun Yuan

Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai China

Qingfeng Li

Shanghai Ninth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai China